COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in Germany

OBJECTIVE: We aimed to estimate the incidence of cerebral sinus and venous thrombosis (CVT) within 1 month from first dose administration and the frequency of vaccine‐induced immune thrombotic thrombocytopenia (VITT) as the underlying mechanism after vaccination with BNT162b2, ChAdOx1, and mRNA‐1273...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Jörg B., Berlit, Peter, Diener, Hans‐Christoph, Gerloff, Christian, Greinacher, Andreas, Klein, Christine, Petzold, Gabor C., Piccininni, Marco, Poli, Sven, Röhrig, Rainer, Steinmetz, Helmuth, Thiele, Thomas, Kurth, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427115/
https://www.ncbi.nlm.nih.gov/pubmed/34288044
http://dx.doi.org/10.1002/ana.26172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427115/
https://www.ncbi.nlm.nih.gov/pubmed/34288044
http://dx.doi.org/10.1002/ana.26172

Ejemplares similares